Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2017-11-08

FDA Approved: VIBERZI — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's supplemental application for VIBERZI (eluxadoline), updating the labeling for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viberzi (eluxadoline)

Snippet

SUPPL AP for VIBERZI (ELUXADOLINE)